Skip to content

Hubbell HUBB Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By geography

See full
International9%-10.0%

Other financials

Income statement

See full
Revenue$1.5B+11.1%
Gross profit$505.3M+14.2%
Operating income$263.8M+14.5%
Net income$181.8M+11.4%
EPS (diluted)$3.41+12.5%

Balance sheet

See full
Cash & equivalents$501.6M+44.6%
Total debt$2.2B+84.3%
Total equity$3.8B+15.6%
Total assets$8.4B+21.6%

Cash flow

See full
Operating cash flow$86.6M+132%
CapEx$40.6M+56.2%
Free cash flow$46.0M+304%

Valuation

See full
Market cap$27.65B+19.0%
Enterprise value$29.35B+22.3%
P/E30.5×+2.6×
P/S4.6×+0.5×

Profitability

See full
Gross margin35.5%+1.2pp
Operating margin20.7%+0.9pp
Net margin15.1%+0.7pp
FCF margin15.2%+1.4pp

Returns & leverage

See full
Return on equity25.8%-0.2pp
Debt / equity0.6×+0.2×
Current ratio1.6×+0.4×